Company Profile
Topcare pharmaceutical Co., Ltd is a new high-tech enterprise, which has leading superority on new drugs research & development, API and pharmaceutical intermediate. We are devoted to the pharmaceutical technology-related services and manufacturing, based on chemcial synthesis and drug analysis.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(R)-Lansoprazole |
1H-Benzimidazole,2-[(R)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-;1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-,(R)-;2-[(R)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;(+)-Lansoprazole;R-(+)-Lansoprazole;(R)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole;(R)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;Dexlansoprazole;(R)-Lansoprazole;T 168390;TAK 390;Dexilant;Dextrolansoprazole;(+)-Lansoprazol;2-[(R)-[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole;1336907-93-7 |
138530-94-6 | Pharma Grade / 99% | Inquiry |
2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride |
Pyridine,2-(chloromethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)-,hydrochloride (1:1);Pyridine,2-(chloromethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)-,hydrochloride;2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride |
127337-60-4 | Pharma Grade / 99% | Inquiry |
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile |
4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile;BENZONITRILE, 4,5-BIS(2-METHOXYETHOXY)-2-NITRO-;Erlotinib Impurity 13;4-5-bis(2-methoxyethoxy)-2-nitrobenzonitrile;SCHEMBL482018;CTK4F2022;KS-00000QIU;DTXSID40581646;BCP08819;ANW-67559 |
236750-65-5 | - / 99% | Inquiry |
7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one |
4(3H)-Quinazolinone,7-methoxy-6-[3-(4-morpholinyl)propoxy]-;4(1H)-Quinazolinone,7-methoxy-6-[3-(4-morpholinyl)propoxy]-;7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone;7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one;7-Methoxy-6-(3-(morpholin-4-yl)propoxy)-3H-quinazolin-4-one;7-Methoxy-6-[3-(4-morpholinyl)propoxy]quinazolin-4(3H)-one;7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4-one |
199327-61-2 | - / 99% | Inquiry |
Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate |
1H-Pyrrole-3-carboxylic acid,5-formyl-2,4-dimethyl-,ethyl ester;Pyrrole-3-carboxylic acid,5-formyl-2,4-dimethyl-,ethyl ester;Ethyl 2-formyl-3,5-dimethylpyrrole-4-carboxylate;Ethyl 5-formyl-2,4-dimethylpyrrole-3-carboxylate;Ethyl 2,4-dimethyl-5-formylpyrrole-3-carboxylate;2,4-Dimethyl-3-ethoxycarbonyl-5-formylpyrrole;5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester;NSC 13426;4-Ethoxycarbonyl-3,5-dimethylpyrrole-2-carboxaldehyde;Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate |
2199-59-9 | - / 99% | Inquiry |
Hydroxylamine |
Hydroxylamine;Hydroxyamine;Telclean 1200A;HDA;EKC 270T |
7803-49-8 | - / 98% | Inquiry |
IPTG 367-93-1 Isopropyl-beta-D-thiogalactopyranoside |
β-D-Galactopyranoside,1-methylethyl 1-thio-;Galactopyranoside,isopropyl 1-thio-,β-D-;Galactopyranoside,isopropyl 1-thio-;1-Methylethyl 1-thio-β-D-galactopyranoside;IPTG;Isopropyl β-D-thiogalactopyranoside;Isopropyl β-thiogalactopyranoside;Thioisopropyl β-D-galactopyranoside;Isopropyl thio-β-D-galactoside;Isopropyl 1-thio-β-D-galactoside;Isopropyl β-thiogalactoside;Isopropyl thio-β-D-galactopyranoside;Isopropyl 1-thio-β-D-galactopyranoside;Isopropyl-β-D-1-thiogalactopyranoside;1: PN: CN105175524 PAGE: 2 claimed sequence;30323-26-3;1044658-74-3 |
367-93-1 | - / 98% | Inquiry |
Sunitinib intermediate 253870-02-9 |
1H-Pyrrole-3-carboxylic acid,5-formyl-2,4-dimethyl-;5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid;5-Formyl-2,4-dimethylpyrrole-3-carboxylic acid;2,4-Dimethyl-5-formyl-1H-pyrrole-3-carboxylic acid;2,4-Dimethyl-5-formylpyrrole-3-carboxylic acid |
253870-02-9 | - / 99% | Inquiry |
SUNITINIB MALATE 341031-54-7 |
Butanedioic acid,2-hydroxy-,(2S)-,compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);Butanedioic acid,hydroxy-,(2S)-,compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);1H-Pyrrole-3-carboxamide,N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-,(2S)-hydroxybutanedioate (1:1);Sunitinib malate;SU 011248;SU 11248;Sutent;Sunitinib L-malate;Sunitinib L-malate |
341031-54-7 | - / 99% | Inquiry |
CONTACT INFORMATION
Sign In for Details